Deciphering deamidation and isomerization in therapeutic proteins: Effect of neighboring residue

References

• Jain T, Sun T, Durand S, Hall A, Houston NR, Nett JH, Sharkey B, Bobrowicz B, Caffry I, Yu Y, et al. Biophysical properties of the clinical-stage antibody landscape. Proc Natl Acad Sci U S A. 2017;114(5):944–14. doi:10.1073/pnas.1616408114.
   PubMed Web of Science ®Google Scholar
• Raybould MIJ, Marks C, Krawczyk K, Taddese B, Nowak J, Lewis AP, Bujotzek A, Shi J, Deane CM. Five computational developability guidelines for therapeutic antibody profiling. Proc Natl Acad Sci U S A. 2019;116:4025–30. doi:10.1073/pnas.1810576116.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang D, Mason B, Rossomando T, Li N, Liu D, Cheung JK, Xu W, Raghava S, Katiyar A, et al. Structure, heterogeneity and developability assessment of therapeutic antibodies. MAbs. 2019;11(2):239–64. doi:10.1080/19420862.2018.1553476.
   PubMed Web of Science ®Google Scholar
• Robinson NE, Robinson AB. Deamidation of human proteins. Proc Natl Acad Sci U S A. 2001;98:12409–13. doi:10.1073/pnas.221463198.
   PubMed Web of Science ®Google Scholar
• Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol. 2006;24:1241–52. doi:10.1038/nbt1252.
   PubMed Web of Science ®Google Scholar
• Klimova N, Long A, Kristian T. Significance of Mitochondrial Protein Post-translational Modifications in Pathophysiology of Brain Injury. Transl Stroke Res. 2018;9:223–37. doi:10.1007/s12975-017-0569-8.
   PubMed Web of Science ®Google Scholar
• Giles AR, Sims JJ, Turner KB, Govindasamy L, Alvira MR, Lock M, Wilson JM. Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector Function. Mol Ther. 2018;26:2848–62. doi:10.1016/j.ymthe.2018.09.013.
   PubMed Web of Science ®Google Scholar
• Jiskoot W, Randolph TW, Volkin DB, Middaugh CR, Schoneich C, Winter G, Friess W, Crommelin DJ, Carpenter JF. Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release. J Pharm Sci. 2012;101:946–54. doi:10.1002/jps.23018.
   PubMed Web of Science ®Google Scholar
• Krause ME, Sahin E. Chemical and physical instabilities in manufacturing and storage of therapeutic proteins. Curr Opin Biotechnol. 2019;60:159–67. doi:10.1016/j.copbio.2019.01.014.
   PubMed Web of Science ®Google Scholar
• Strader MB, Jana S, Meng F, Heaven MR, Shet AS, Thein SL, Alayash AI. Post-translational modification as a response to cellular stress induced by hemoglobin oxidation in sickle cell disease. Sci Rep. 2020;10:14218. doi:10.1038/s41598-020-71096-6.
   PubMed Web of Science ®Google Scholar
• Zhu MM, Mollet M, Hubert RS, Kyung YS, Zhang GG. Industrial Production of Therapeutic Proteins: cell Lines, Cell Culture, and Purification. In: Kent JA, Bommaraju TV, Barnicki SD, editors. Handbook of Industrial Chemistry and Biotechnology. Cham: Springer International Publishing; 2017. p. 1639–69.
   Google Scholar
• Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, Shire SJ, Bjork N, Totpal K, Chen AB, et al. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B Biomed Sci Appl. 2001;752(2):233–45. doi:10.1016/S0378-4347(00)00548-X.
   PubMedGoogle Scholar
• Reer KJ, Aswad DW. Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals? Cell Mol Life Sci. 2003;60:1281–95. doi:10.1007/s00018-003-2287-5.
   PubMed Web of Science ®Google Scholar
• Patel CN, Bauer SP, Davies J, Durbin JD, Shiyanova TL, Zhang K, Tang JX. N+1 Engineering of an Aspartate Isomerization Hotspot in the Complementarity-Determining Region of a Monoclonal Antibody. J Pharm Sci. 2016;105:512–18. doi:10.1016/S0022-3549(15)00185-9.
   PubMed Web of Science ®Google Scholar
• Salazar-Fontana LI, Desai DD, Khan TA, Pillutla RC, Prior S, Ramakrishnan R, Schneider J, Joseph A. Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development. AAPS J. 2017;19:377–85. doi:10.1208/s12248-016-0030-z.
   PubMed Web of Science ®Google Scholar
• Verma A, Burns DL. Improving the stability of recombinant anthrax protective antigen vaccine. Vaccine. 2018;36:6379–82. doi:10.1016/j.vaccine.2018.09.012.
   PubMed Web of Science ®Google Scholar
• Jia L, Sun Y. Protein asparagine deamidation prediction based on structures with machine learning methods. PLoS One. 2017;12:e0181347. doi:10.1371/journal.pone.0181347.
   PubMed Web of Science ®Google Scholar
• Lorenzo JR, Alonso LG, Sanchez IE. Prediction of Spontaneous Protein Deamidation from Sequence-Derived Secondary Structure and Intrinsic Disorder. PLoS One. 2015;10:e0145186. doi:10.1371/journal.pone.0145186.
   PubMed Web of Science ®Google Scholar
• Robinson NE, Robinson AB. Prediction of protein deamidation rates from primary and three-dimensional structure. Proc Natl Acad Sci U S A. 2001;98:4367–72. doi:10.1073/pnas.071066498.
   PubMed Web of Science ®Google Scholar
• Sydow JF, Lipsmeier F, Larraillet V, Hilger M, Mautz B, Molhoj M, Kuentzer J, Klostermann S, Schoch J, Voelger HR, et al. Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regions. PLoS One. 2014;9(6):e100736. doi:10.1371/journal.pone.0100736.
   PubMed Web of Science ®Google Scholar
• Robinson AB, Rudd CJ. Deamidation of Glutaminyl and Asparaginyl Residues in Peptides and Proteins. In: Horecker BL, Stadtman ER editors. Current Topics in Cellular Regulation. Academic Press; 1974. p. 247–95.
   Google Scholar
• Capasso S, Mazzarella L, Sica F, Zagari A. Deamidation via cyclic imide in asparaginyl peptides. Pept Res. 1989;2:195–200.
   PubMedGoogle Scholar
• Patel K, Borchardt RT. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide. Pharm Res. 1990;7:703–11. doi:10.1023/A:1015807303766.
   PubMed Web of Science ®Google Scholar
• Tyler-Cross R, Schirch V. Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. J Biol Chem. 1991;266:22549–56. doi:10.1016/S0021-9258(18)54607-X.
   PubMed Web of Science ®Google Scholar
• Capasso S, Mazzarella L, Sica F, Zagari A, Salvadori S. Kinetics and mechanism of succinimide ring formation in the deamidation process of asparagine residues. J Chem Soc Perkin Transactions. 2. 1993. 679–82. doi:10.1039/p29930000679
   Google Scholar
• Radkiewicz JL, Zipse H, Clarke S, Houk KN. Accelerated Racemization of Aspartic Acid and Asparagine Residues via Succinimide Intermediates: an ab Initio Theoretical Exploration of Mechanism. J Am Chem Soc. 1996;118:9148–55. doi:10.1021/ja953505b.
   Web of Science ®Google Scholar
• Radkiewicz JL, Zipse H, Clarke S, Houk KN. Neighboring side chain effects on asparaginyl and aspartyl degradation: an ab initio study of the relationship between peptide conformation and backbone NH acidity. J Am Chem Soc. 2001;123:3499–506. doi:10.1021/ja0026814.
   PubMed Web of Science ®Google Scholar
• Ritz-Timme S, Laumeier I, Collins MJ. Aspartic acid racemization: evidence for marked longevity of elastin in human skin. Br J Dermatol. 2003;149:951–59. doi:10.1111/j.1365-2133.2003.05618.x.
   PubMed Web of Science ®Google Scholar
• Catak S, Monard G, Aviyente V, Ruiz-Lopez MF. Reaction mechanism of deamidation of asparaginyl residues in peptides: effect of solvent molecules. J Phys Chem A. 2006;110:8354–65. doi:10.1021/jp056991q.
   PubMed Web of Science ®Google Scholar
• Catak S, Monard G, Aviyente V, Ruiz-Lopez MF. Deamidation of asparagine residues: direct hydrolysis versus succinimide-mediated deamidation mechanisms. J Phys Chem A. 2009;113:1111–20. doi:10.1021/jp808597v.
   PubMed Web of Science ®Google Scholar
• Fogolari F, Esposito G, Viglino P, Briggs JM, McCammon JA. pKaShift Effects on Backbone Amide Base-Catalyzed Hydrogen Exchange Rates in Peptides. J Am Chem Soc. 1998;120:3735–38. doi:10.1021/ja963133m.
   Web of Science ®Google Scholar
• Gamage CLD, Hageman TS, Weis DD. Rapid Prediction of Deamidation Rates of Proteins to Assess Their Long-Term Stability Using Hydrogen Exchange-Mass Spectrometry. J Pharm Sci. 2019;108:1964–72. doi:10.1016/j.xphs.2019.01.019.
   PubMed Web of Science ®Google Scholar
• Robinson NE, Robinson ZW, Robinson BR, Robinson AL, Robinson JA, Robinson ML, Robinson AB. Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides. J Pept Res. 2004;63:426–36. doi:10.1111/j.1399-3011.2004.00151.x.
   PubMedGoogle Scholar
• Lu X, Nobrega RP, Lynaugh H, Jain T, Barlow K, Boland T, Sivasubramanian A, Vasquez M, Xu Y. Deamidation and isomerization liability analysis of 131 clinical-stage antibodies. MAbs. 2019;11:45–57. doi:10.1080/19420862.2018.1548233.
   PubMed Web of Science ®Google Scholar
• Oliva A, Henry B, Ruiz-López MF. Insights on peptide backbone N–H acidity: structure of anions, hydration effects. Chem Phys Lett. 2013;561-562:153–58. doi:10.1016/j.cplett.2013.01.040.
   Web of Science ®Google Scholar
• Plotnikov NV, Singh SK, Rouse JC, Kumar S. Quantifying the Risks of Asparagine Deamidation and Aspartate Isomerization in Biopharmaceuticals by Computing Reaction Free-Energy Surfaces. J Phys Chem B. 2017;121:719–30. doi:10.1021/acs.jpcb.6b11614.
   PubMed Web of Science ®Google Scholar
• Ugur I, Marion A, Aviyente V, Monard G. Why does Asn71 deamidate faster than Asn15 in the enzyme triosephosphate isomerase? Answers from microsecond molecular dynamics simulation and QM/MM free energy calculations. Biochemistry. 2015;54:1429–39. doi:10.1021/bi5008047.
   PubMed Web of Science ®Google Scholar
• Delmar JA, Wang J, Choi SW, Martins JA, Mikhail JP. Machine Learning Enables Accurate Prediction of Asparagine Deamidation Probability and Rate. Mol Ther Methods Clin Dev. 2019;15:264–74. doi:10.1016/j.omtm.2019.09.008.
   PubMed Web of Science ®Google Scholar
• Hamuro Y, SY E. Determination of Backbone Amide Hydrogen Exchange Rates of Cytochrome c Using Partially Scrambled Electron Transfer Dissociation Data. J Am Soc Mass Spectrom. 2018;29:989–1001. doi:10.1007/s13361-018-1892-3.
   PubMed Web of Science ®Google Scholar
• Huang L, So PK, Yao ZP. Protein dynamics revealed by hydrogen/deuterium exchange mass spectrometry: correlation between experiments and simulation. Rapid Commun Mass Spectrom. 2019;33 Suppl 3:83–89. doi:10.1002/rcm.8307.
   PubMed Web of Science ®Google Scholar
• Kosky AA, Razzaq UO, Treuheit MJ, Brems DN. The effects of alpha-helix on the stability of Asn residues: deamidation rates in peptides of varying helicity. Protein Sci. 1999;8:2519–23. doi:10.1110/ps.8.11.2519.
   PubMed Web of Science ®Google Scholar
• Forood B, Feliciano EJ, Nambiar KP. Stabilization of alpha-helical structures in short peptides via end capping. Proc Natl Acad Sci U S A. 1993;90:838–42. doi:10.1073/pnas.90.3.838.
   PubMed Web of Science ®Google Scholar
• Head-Gordon T, Head-Gordon M, Frisch MJ, Brooks C, Pople J. A theoretical study of alanine dipeptide and analogs. Int J Quantum Chem. 2009;36:311–22. doi:10.1002/qua.560360725.
   Google Scholar
• Diepold K, Bomans K, Wiedmann M, Zimmermann B, Petzold A, Schlothauer T, Mueller R, Moritz B, Stracke JO, Mølhøj M, et al. Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures. PLoS One. 2012;7(1):e30295. doi:10.1371/journal.pone.0030295.
   PubMed Web of Science ®Google Scholar
• Wakankar AA, Borchardt RT, Eigenbrot C, Shia S, Wang YJ, Shire SJ, Liu JL. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies. Biochemistry. 2007;46:1534–44. doi:10.1021/bi061500t.
   PubMed Web of Science ®Google Scholar
• Yan B, Steen S, Hambly D, Valliere-Douglass J, Vanden Bos T, Smallwood S, Yates Z, Arroll T, Han Y, Gadgil H, et al. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. J Pharm Sci. 2009;98(10):3509–21. doi:10.1002/jps.21655.
   PubMed Web of Science ®Google Scholar
• Pace AL, Wong RL, Zhang YT, Kao YH, Wang YJ. Asparagine deamidation dependence on buffer type, pH, and temperature. J Pharm Sci. 2013;102:1712–23. doi:10.1002/jps.23529.
   PubMed Web of Science ®Google Scholar
• Sreedhara A, Cordoba A, Zhu Q, Kwong J, Liu J. Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody. Pharm Res. 2012;29:187–97. doi:10.1007/s11095-011-0534-2.
   PubMed Web of Science ®Google Scholar
• Rehder DS, Chelius D, McAuley A, Dillon TM, Xiao G, Crouse-Zeineddini J, Vardanyan L, Perico N, Mukku V, Brems DN, et al. Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity. Biochemistry. 2008;47(8):2518–30. doi:10.1021/bi7018223.
   PubMed Web of Science ®Google Scholar
• Barducci A, Bussi G, Parrinello M. Well-tempered metadynamics: a smoothly converging and tunable free-energy method. Phys Rev Lett. 2008;100:020603. doi:10.1103/PhysRevLett.100.020603.
   PubMed Web of Science ®Google Scholar
• Knapp B, Ospina L, Deane CM. Avoiding False Positive Conclusions in Molecular Simulation: the Importance of Replicas. J Chem Theory Comput. 2018;14:6127–38. doi:10.1021/acs.jctc.8b00391.
   PubMed Web of Science ®Google Scholar
• Frisch M, Trucks G, Schlegel H, Scuseria G, Robb M, Cheeseman J, Scalmani G, Barone V, Mennucci B, Petersson G. GAUSSIAN09. Wallingford (CT, USA): Gaussian Inc; 2009
   Google Scholar
• Stewart J. MOPAC2016; Stewart Computational Chemistry. Colorado Springs (CO): Google Scholar There is no corresponding record for this reference; 2016.
   Google Scholar
• Hostaš J, Řezáč J, Hobza P. On the performance of the semiempirical quantum mechanical PM6 and PM7 methods for noncovalent interactions. Chem Phys Lett. 2013;568:161–66. doi:10.1016/j.cplett.2013.02.069.
   Web of Science ®Google Scholar
• Kromann JC, Christensen AS, Steinmann C, Korth M, Jensen JH. A third-generation dispersion and third-generation hydrogen bonding corrected PM6 method: PM6-D3H+. PeerJ. 2014;2:e449. doi:10.7717/peerj.449.
   PubMed Web of Science ®Google Scholar
• O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011;3:33. doi:10.1186/1758-2946-3-33.
   PubMed Web of Science ®Google Scholar
• Ari N, Ustazhanov M. Matplotlib in python. 11th International Conference on Electronics, Computer and Computation (ICECCO): IEEE, 2014:1–6.
   Google Scholar
• Dunbar J, Krawczyk K, Leem J, Baker T, Fuchs A, Georges G, Shi J, Deane CM. SAbDab: the structural antibody database. Nucleic Acids Res. 2014;42:D1140–6. doi:10.1093/nar/gkt1043.
   PubMed Web of Science ®Google Scholar
• Raybould MIJ, Marks C, Lewis AP, Shi J, Bujotzek A, Taddese B, Deane CM. Thera-SAbDab: the Therapeutic Structural Antibody Database. Nucleic Acids Res. 2020;48:D383–D8. doi:10.1093/nar/gkz827.
   PubMed Web of Science ®Google Scholar
• Gowers RJ, Linke M, Barnoud J, Reddy TJE, Melo MN, Seyler SL, Domanski J, Dotson DL, Buchoux S, Kenney IM. MDAnalysis: a Python package for the rapid analysis of molecular dynamics simulations. Los Alamos National Lab.(LANL), Los Alamos, NM (United States); 2019.
   Google Scholar
• Nguyen H, Roe DR, Swails J, Case DA. PYTRAJ: interactive data analysis for molecular dynamics simulations. New Brunswick (NJ): Rutgers University; 2016.
   Google Scholar
• Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V. Scikit-learn: machine learning in Python. J Machine Learning Res. 2011;12:2825–30.
   Web of Science ®Google Scholar
• Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem. 2008;8:1555–72. doi:10.2174/156802608786786624.
   PubMed Web of Science ®Google Scholar
• Case DA, Berryman JT, Betz RM, Cerutti DS, Cheatham TE, Darden I, Duke TA, Giese RE, Gohlke TJ, Goetz H, et al. AMBER 2015. UCSF. 2015.
   Google Scholar
• Price DJ, Brooks CL. A modified TIP3P water potential for simulation with Ewald summation. J Chem Phys. 2004;121:10096–103. doi:10.1063/1.1808117.
   PubMed Web of Science ®Google Scholar
• Hopkins CW, Le Grand S, Walker RC, Roitberg AE. Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning. J Chem Theory Comput. 2015;11:1864–74. doi:10.1021/ct5010406.
   PubMed Web of Science ®Google Scholar
• Sanner MF, Olson AJ, Spehner JC. Reduced surface: an efficient way to compute molecular surfaces. Biopolymers. 1996;38:305–20. doi:10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y.
   PubMed Web of Science ®Google Scholar
• Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19–25. doi:10.1016/j.softx.2015.06.001.
   Google Scholar
• Tribello GA, Bonomi M, Branduardi D, Camilloni C, Bussi G. PLUMED 2: new feathers for an old bird. Comput Phys Commun. 2014;185:604–13. doi:10.1016/j.cpc.2013.09.018.
   Web of Science ®Google Scholar
• Bonomi M, Barducci A, Parrinello M. Reconstructing the equilibrium Boltzmann distribution from well-tempered metadynamics. J Comput Chem. 2009;30:1615–21. doi:10.1002/jcc.21305.
   PubMed Web of Science ®Google Scholar